Loading…

Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes

Dengue is among the most rapidly spreading arboviral disease in the world. A low-cost, easy to use point-of-care diagnostic tool for the detection and differentiation of dengue virus serotypes could improve clinical management, disease prevention, epidemiological surveillance, and outbreak monitorin...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2022-03, Vol.13, p.852452-852452
Main Authors: Lai, Szu-Chia, Huang, Yu-Yine, Wey, Jiunn-Jye, Tsai, Meng-Hung, Chen, Yi-Ling, Shu, Pei-Yun, Chang, Shu-Fen, Hung, Yi-Jen, Hou, Jiu-Nan, Lin, Chang-Chi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703
cites cdi_FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703
container_end_page 852452
container_issue
container_start_page 852452
container_title Frontiers in immunology
container_volume 13
creator Lai, Szu-Chia
Huang, Yu-Yine
Wey, Jiunn-Jye
Tsai, Meng-Hung
Chen, Yi-Ling
Shu, Pei-Yun
Chang, Shu-Fen
Hung, Yi-Jen
Hou, Jiu-Nan
Lin, Chang-Chi
description Dengue is among the most rapidly spreading arboviral disease in the world. A low-cost, easy to use point-of-care diagnostic tool for the detection and differentiation of dengue virus serotypes could improve clinical management, disease prevention, epidemiological surveillance, and outbreak monitoring, particularly in regions where multiple serotypes co-circulate. Despite widespread deployment, no commercial dengue antigen diagnostic test has proven effective in differentiating among dengue virus serotypes. In the current study, we first established mAb pairs and developed a multiplex lateral flow immunoassay for the simultaneous detection of the dengue viral NS1 antigen and identification of serotype. The proposed system, called Dengue serotype NS1 Multiplex LFIA, provides high sensitivity and specificity. In testing for JEV, ZIKV, YFV, WNV, and CHIKV, the multiplex LFIA gave no indication of cross- reactivity with cell culture supernatants of other flaviviruses or chikungunya virus. In analyzing 187 samples from patients suspected of dengue infection, the detection sensitivity for serotype D1 to D4 was 90.0%, 88.24%, 82.61%, and 83.33% and serotype specificity was 98.74%, 96.13%, 99.39%, and 97.04%, respectively. Our multiplex LFIA can also identify mono- and co-infection of different serotype of dengue viruses in mosquitoes. The proposed Multiplex LFIA provides a simple tool for the rapid detection of dengue serotypes and in the differential diagnosis of fever patients in regions where medical resources are limited and/or multiple DENVs co-circulate.
doi_str_mv 10.3389/fimmu.2022.852452
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0f4801318ea84d5baeec83dae23faaa4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0f4801318ea84d5baeec83dae23faaa4</doaj_id><sourcerecordid>2641515083</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703</originalsourceid><addsrcrecordid>eNpVks9u1DAQxiMEolXpA3BBPnLZxfGfxL4gVV0KK20LUuFsTZzx1lUSp7FT2BfhefF2S9X6YHs83_zGtr6ieF_SJedKf3K-7-clo4wtlWRCslfFcVlVYsEZE6-f7Y-K0xhvaR5Cc87l2-KIS041Z-q4-LvCe-zC2OOQSHDkKuSQrHDYzkiurktyOXfJjx3-IRtIOEFHLrrwm6xz8yFAjLAjKZCVdw6nzPBZRK5xCmk3YiR-2Adzv0ef2TnnftxAzDMkn9WRwNCS9eDQJmzJZYh3s08B47vijYMu4unjelL8uvjy8_zbYvP96_r8bLOwopJpoYSgWoDGiiJXjHPWcKtbrCvNONgGSsWoqOuaugaU5C21TSu1pZVjWtaUnxTrA7cNcGvGyfcw7UwAbx4OwrQ1MCVvOzTUCUVLXioEJVrZAKJVvAVk3AGAyKzPB9Y4Nz22Nr8vf9cL6MvM4G_MNtwbpXnJdJ0BHx8BU7ibMSbT-2ix62DAMEfDKlHKUlLFs7Q8SO0UYpzQPbUpqdnbwzzYw-ztYQ72yDUfnt_vqeK_Gfg_W8O53g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641515083</pqid></control><display><type>article</type><title>Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes</title><source>PubMed Central(OpenAccess)</source><creator>Lai, Szu-Chia ; Huang, Yu-Yine ; Wey, Jiunn-Jye ; Tsai, Meng-Hung ; Chen, Yi-Ling ; Shu, Pei-Yun ; Chang, Shu-Fen ; Hung, Yi-Jen ; Hou, Jiu-Nan ; Lin, Chang-Chi</creator><creatorcontrib>Lai, Szu-Chia ; Huang, Yu-Yine ; Wey, Jiunn-Jye ; Tsai, Meng-Hung ; Chen, Yi-Ling ; Shu, Pei-Yun ; Chang, Shu-Fen ; Hung, Yi-Jen ; Hou, Jiu-Nan ; Lin, Chang-Chi</creatorcontrib><description>Dengue is among the most rapidly spreading arboviral disease in the world. A low-cost, easy to use point-of-care diagnostic tool for the detection and differentiation of dengue virus serotypes could improve clinical management, disease prevention, epidemiological surveillance, and outbreak monitoring, particularly in regions where multiple serotypes co-circulate. Despite widespread deployment, no commercial dengue antigen diagnostic test has proven effective in differentiating among dengue virus serotypes. In the current study, we first established mAb pairs and developed a multiplex lateral flow immunoassay for the simultaneous detection of the dengue viral NS1 antigen and identification of serotype. The proposed system, called Dengue serotype NS1 Multiplex LFIA, provides high sensitivity and specificity. In testing for JEV, ZIKV, YFV, WNV, and CHIKV, the multiplex LFIA gave no indication of cross- reactivity with cell culture supernatants of other flaviviruses or chikungunya virus. In analyzing 187 samples from patients suspected of dengue infection, the detection sensitivity for serotype D1 to D4 was 90.0%, 88.24%, 82.61%, and 83.33% and serotype specificity was 98.74%, 96.13%, 99.39%, and 97.04%, respectively. Our multiplex LFIA can also identify mono- and co-infection of different serotype of dengue viruses in mosquitoes. The proposed Multiplex LFIA provides a simple tool for the rapid detection of dengue serotypes and in the differential diagnosis of fever patients in regions where medical resources are limited and/or multiple DENVs co-circulate.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2022.852452</identifier><identifier>PMID: 35309328</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Animals ; Antibodies, Monoclonal ; Antibodies, Viral ; Culicidae ; Dengue ; Dengue Virus ; Humans ; Immunoassay ; Immunology ; lateral flow immunoassay ; NS1 ; rapid test ; Serogroup ; serotype ; Viral Nonstructural Proteins ; Zika Virus ; Zika Virus Infection</subject><ispartof>Frontiers in immunology, 2022-03, Vol.13, p.852452-852452</ispartof><rights>Copyright © 2022 Lai, Huang, Wey, Tsai, Chen, Shu, Chang, Hung, Hou and Lin.</rights><rights>Copyright © 2022 Lai, Huang, Wey, Tsai, Chen, Shu, Chang, Hung, Hou and Lin 2022 Lai, Huang, Wey, Tsai, Chen, Shu, Chang, Hung, Hou and Lin</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703</citedby><cites>FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931297/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931297/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35309328$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lai, Szu-Chia</creatorcontrib><creatorcontrib>Huang, Yu-Yine</creatorcontrib><creatorcontrib>Wey, Jiunn-Jye</creatorcontrib><creatorcontrib>Tsai, Meng-Hung</creatorcontrib><creatorcontrib>Chen, Yi-Ling</creatorcontrib><creatorcontrib>Shu, Pei-Yun</creatorcontrib><creatorcontrib>Chang, Shu-Fen</creatorcontrib><creatorcontrib>Hung, Yi-Jen</creatorcontrib><creatorcontrib>Hou, Jiu-Nan</creatorcontrib><creatorcontrib>Lin, Chang-Chi</creatorcontrib><title>Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Dengue is among the most rapidly spreading arboviral disease in the world. A low-cost, easy to use point-of-care diagnostic tool for the detection and differentiation of dengue virus serotypes could improve clinical management, disease prevention, epidemiological surveillance, and outbreak monitoring, particularly in regions where multiple serotypes co-circulate. Despite widespread deployment, no commercial dengue antigen diagnostic test has proven effective in differentiating among dengue virus serotypes. In the current study, we first established mAb pairs and developed a multiplex lateral flow immunoassay for the simultaneous detection of the dengue viral NS1 antigen and identification of serotype. The proposed system, called Dengue serotype NS1 Multiplex LFIA, provides high sensitivity and specificity. In testing for JEV, ZIKV, YFV, WNV, and CHIKV, the multiplex LFIA gave no indication of cross- reactivity with cell culture supernatants of other flaviviruses or chikungunya virus. In analyzing 187 samples from patients suspected of dengue infection, the detection sensitivity for serotype D1 to D4 was 90.0%, 88.24%, 82.61%, and 83.33% and serotype specificity was 98.74%, 96.13%, 99.39%, and 97.04%, respectively. Our multiplex LFIA can also identify mono- and co-infection of different serotype of dengue viruses in mosquitoes. The proposed Multiplex LFIA provides a simple tool for the rapid detection of dengue serotypes and in the differential diagnosis of fever patients in regions where medical resources are limited and/or multiple DENVs co-circulate.</description><subject>Animals</subject><subject>Antibodies, Monoclonal</subject><subject>Antibodies, Viral</subject><subject>Culicidae</subject><subject>Dengue</subject><subject>Dengue Virus</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Immunology</subject><subject>lateral flow immunoassay</subject><subject>NS1</subject><subject>rapid test</subject><subject>Serogroup</subject><subject>serotype</subject><subject>Viral Nonstructural Proteins</subject><subject>Zika Virus</subject><subject>Zika Virus Infection</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks9u1DAQxiMEolXpA3BBPnLZxfGfxL4gVV0KK20LUuFsTZzx1lUSp7FT2BfhefF2S9X6YHs83_zGtr6ieF_SJedKf3K-7-clo4wtlWRCslfFcVlVYsEZE6-f7Y-K0xhvaR5Cc87l2-KIS041Z-q4-LvCe-zC2OOQSHDkKuSQrHDYzkiurktyOXfJjx3-IRtIOEFHLrrwm6xz8yFAjLAjKZCVdw6nzPBZRK5xCmk3YiR-2Adzv0ef2TnnftxAzDMkn9WRwNCS9eDQJmzJZYh3s08B47vijYMu4unjelL8uvjy8_zbYvP96_r8bLOwopJpoYSgWoDGiiJXjHPWcKtbrCvNONgGSsWoqOuaugaU5C21TSu1pZVjWtaUnxTrA7cNcGvGyfcw7UwAbx4OwrQ1MCVvOzTUCUVLXioEJVrZAKJVvAVk3AGAyKzPB9Y4Nz22Nr8vf9cL6MvM4G_MNtwbpXnJdJ0BHx8BU7ibMSbT-2ix62DAMEfDKlHKUlLFs7Q8SO0UYpzQPbUpqdnbwzzYw-ztYQ72yDUfnt_vqeK_Gfg_W8O53g</recordid><startdate>20220304</startdate><enddate>20220304</enddate><creator>Lai, Szu-Chia</creator><creator>Huang, Yu-Yine</creator><creator>Wey, Jiunn-Jye</creator><creator>Tsai, Meng-Hung</creator><creator>Chen, Yi-Ling</creator><creator>Shu, Pei-Yun</creator><creator>Chang, Shu-Fen</creator><creator>Hung, Yi-Jen</creator><creator>Hou, Jiu-Nan</creator><creator>Lin, Chang-Chi</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220304</creationdate><title>Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes</title><author>Lai, Szu-Chia ; Huang, Yu-Yine ; Wey, Jiunn-Jye ; Tsai, Meng-Hung ; Chen, Yi-Ling ; Shu, Pei-Yun ; Chang, Shu-Fen ; Hung, Yi-Jen ; Hou, Jiu-Nan ; Lin, Chang-Chi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal</topic><topic>Antibodies, Viral</topic><topic>Culicidae</topic><topic>Dengue</topic><topic>Dengue Virus</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Immunology</topic><topic>lateral flow immunoassay</topic><topic>NS1</topic><topic>rapid test</topic><topic>Serogroup</topic><topic>serotype</topic><topic>Viral Nonstructural Proteins</topic><topic>Zika Virus</topic><topic>Zika Virus Infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lai, Szu-Chia</creatorcontrib><creatorcontrib>Huang, Yu-Yine</creatorcontrib><creatorcontrib>Wey, Jiunn-Jye</creatorcontrib><creatorcontrib>Tsai, Meng-Hung</creatorcontrib><creatorcontrib>Chen, Yi-Ling</creatorcontrib><creatorcontrib>Shu, Pei-Yun</creatorcontrib><creatorcontrib>Chang, Shu-Fen</creatorcontrib><creatorcontrib>Hung, Yi-Jen</creatorcontrib><creatorcontrib>Hou, Jiu-Nan</creatorcontrib><creatorcontrib>Lin, Chang-Chi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lai, Szu-Chia</au><au>Huang, Yu-Yine</au><au>Wey, Jiunn-Jye</au><au>Tsai, Meng-Hung</au><au>Chen, Yi-Ling</au><au>Shu, Pei-Yun</au><au>Chang, Shu-Fen</au><au>Hung, Yi-Jen</au><au>Hou, Jiu-Nan</au><au>Lin, Chang-Chi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2022-03-04</date><risdate>2022</risdate><volume>13</volume><spage>852452</spage><epage>852452</epage><pages>852452-852452</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Dengue is among the most rapidly spreading arboviral disease in the world. A low-cost, easy to use point-of-care diagnostic tool for the detection and differentiation of dengue virus serotypes could improve clinical management, disease prevention, epidemiological surveillance, and outbreak monitoring, particularly in regions where multiple serotypes co-circulate. Despite widespread deployment, no commercial dengue antigen diagnostic test has proven effective in differentiating among dengue virus serotypes. In the current study, we first established mAb pairs and developed a multiplex lateral flow immunoassay for the simultaneous detection of the dengue viral NS1 antigen and identification of serotype. The proposed system, called Dengue serotype NS1 Multiplex LFIA, provides high sensitivity and specificity. In testing for JEV, ZIKV, YFV, WNV, and CHIKV, the multiplex LFIA gave no indication of cross- reactivity with cell culture supernatants of other flaviviruses or chikungunya virus. In analyzing 187 samples from patients suspected of dengue infection, the detection sensitivity for serotype D1 to D4 was 90.0%, 88.24%, 82.61%, and 83.33% and serotype specificity was 98.74%, 96.13%, 99.39%, and 97.04%, respectively. Our multiplex LFIA can also identify mono- and co-infection of different serotype of dengue viruses in mosquitoes. The proposed Multiplex LFIA provides a simple tool for the rapid detection of dengue serotypes and in the differential diagnosis of fever patients in regions where medical resources are limited and/or multiple DENVs co-circulate.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35309328</pmid><doi>10.3389/fimmu.2022.852452</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2022-03, Vol.13, p.852452-852452
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0f4801318ea84d5baeec83dae23faaa4
source PubMed Central(OpenAccess)
subjects Animals
Antibodies, Monoclonal
Antibodies, Viral
Culicidae
Dengue
Dengue Virus
Humans
Immunoassay
Immunology
lateral flow immunoassay
NS1
rapid test
Serogroup
serotype
Viral Nonstructural Proteins
Zika Virus
Zika Virus Infection
title Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A11%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Novel%20Dengue%20NS1%20Multiplex%20Lateral%20Flow%20Immunoassay%20to%20Differentiate%20Serotypes%20in%20Serum%20of%20Acute%20Phase%20Patients%20and%20Infected%20Mosquitoes&rft.jtitle=Frontiers%20in%20immunology&rft.au=Lai,%20Szu-Chia&rft.date=2022-03-04&rft.volume=13&rft.spage=852452&rft.epage=852452&rft.pages=852452-852452&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2022.852452&rft_dat=%3Cproquest_doaj_%3E2641515083%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-844094a9e60e382332b3c9de76923acba182047770fba853d0cbd59c06f295703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2641515083&rft_id=info:pmid/35309328&rfr_iscdi=true